EUVIMEDOpdag EUVIMED
EditorialOpen access · CC BY 4.0

Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development

Andreas Halman iD, Ross Corriden

Pharmacology Research & Perspectives · 2026-08 · 14 (4)

DOI: 10.1002/prp2.70309 ↗

At a glance

Editorial in Pharmacology Research & Perspectives, published online on 2026-07-29. Written by Andreas Halman and 1 co-authors. Institution: Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia. 6 references. The full text is freely available (open access, CC BY 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Intet abstract tilgængeligt.

Authors and institutions

  • Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
  • Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Victoria, Australia.
  • Cancer Therapies, Stem Cell Medicine, Murdoch Children's Research Institute, Parkville, Victoria, Australia.
  • Pharmacology Research & Perspectives Editorial Board, New Castle, New South Wales, Australia.

ORCID profiles: Andreas Halman

Cite

APA

Halman, A., & Corriden, R. (2026). Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development. Pharmacology Research & Perspectives, 14(4). https://doi.org/10.1002/prp2.70309

Vancouver

Halman A, Corriden R. Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development. Pharmacology Research & Perspectives. 2026;14(4). doi:10.1002/prp2.70309

BibTeX
@article{Halman2026,
  author = {Halman, Andreas and Corriden, Ross},
  title = {Special Issue on the Promise of Psychedelic Pharmacology in Neuropsychiatric Drug Development},
  journal = {Pharmacology Research & Perspectives},
  year = {2026},
  volume = {14},
  number = {4},
  doi = {10.1002/prp2.70309}
}
Start for free →